Impact of Robotic Assistance on Minimally Invasive Surgery for Type II Endometrial Cancer: A National Cancer Database Analysis.

conversion to laparotomy overall survival robotic surgery type II histology uterine cancer

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
19 Jul 2024
Historique:
received: 28 05 2024
revised: 13 07 2024
accepted: 15 07 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

The objective of this study is to compare the overall survival (OS) and surgical outcomes between conventional laparoscopy and robot-assisted laparoscopy (RAL) in women with type II endometrial cancer. We identified a large cohort of women who underwent hysterectomy for type II endometrial cancer between January 2010 and December 2014 using the National Cancer Database (NCDB). The primary outcome was to compare the OS of conventional laparoscopy versus RAL. Secondary outcomes included the length of hospital stay, 30-day readmission rate, 90-day mortality, rates of lymph node retrieval, rates of node positivity, and rates of conversion to laparotomy. Cohorts were compared and multivariable logistic regression was used to determine characteristics with statistically significant predictors of outcome. We identified 7168 patients with stage I-III type II endometrial cancer who had minimally invasive surgery as primary treatment between 2010 and 2014. A total of 5074 patients underwent RAL. Women who underwent RAL were less likely to have stage III disease (26.4% vs. 29.9%,

Identifiants

pubmed: 39061223
pii: cancers16142584
doi: 10.3390/cancers16142584
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Kelly Lamiman (K)

Department of Gynecologic Oncology, Maimonides Medical Center, Brooklyn, NY 11220, USA.

Michael Silver (M)

Department of Gynecologic Oncology, Maimonides Medical Center, Brooklyn, NY 11220, USA.

Nicole Goncalves (N)

Department of Gynecologic Oncology, Maimonides Medical Center, Brooklyn, NY 11220, USA.

Michael Kim (M)

Department of Obstetrics and Gynecology, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY 11215, USA.

Ioannis Alagkiozidis (I)

Department of Gynecologic Oncology, Maimonides Medical Center, Brooklyn, NY 11220, USA.

Classifications MeSH